StockDuty ← Dashboard Aug 26, 2026 12:02 PM ET
CatalystFDA/Bio

TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer

Phase 3 trial initiation marks clinical progress for Datroway in high-risk urothelial cancer.

Phase 3 trial initiation marks clinical progress for Datroway in high-risk urothelial cancer.
Sources